Daily use of a prescription-grade fish oil pill, first marketed by GlaxoSmithKline before going generic, failed to prevent serious cardiovascular events or death in people with diabetes, according to results from a large clinical trial presented Sunday.
The negative outcome of the study, called ASCEND, adds to the growing body of scientific evidence casting doubt on the long-term heart benefit of products containing omega-3 fatty acids.
It also does no favors for Amarin, which is hoping to upend the emboldened fish oil skepticism when a large cardiovascular outcomes study of its own product Vascepa reads out in September.
About the Author Reprints
Triglycerides hovering around 50 as a result of fish oil so it definitely works. Big pharmaceutical at it again
Why do they sell. Them and the doctors tell you about them.
The study was flawed. The people mostly were already compromised. Fish oil isn’t gonna cure or help people who are sick.
It’s an ongoing positive addition that helps. But it’s not a cure.
Also I read somewhere that the study did not include sudden deaths. Which makes no sense, and I’m not sure I read that right.
Need to check into it more.
Fish oil helps make blood slippery so maybe the deposits don’t stick. At least that’s what I hear. Works here.
The fish oil seemed to help drop my number. And hair health!
A combination of fish oil,glucosamine,and turmeric, help my rheumatoid arthritis greatly,
Aim interested in learning more